相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The CRESS checklist for reporting stability studies: on behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase (WG-PRE)
Michael Cornes et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)
Evaluation of a Pilot Vancomycin Precision Dosing Advisory Service on Target Exposure Attainment Using an Interrupted Time Series Analysis
Sophie L. Stocker et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
The monitoring of vancomycin: a systematic review and meta-analyses of area under the concentration-time curve-guided dosing and trough-guided dosing
Moeko Tsutsuura et al.
BMC INFECTIOUS DISEASES (2021)
Accuracy of documented administration times for intravenous antimicrobial drugs and impact on dosing decisions
Stephanie A. Roydhouse et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2021)
Are vancomycin dosing guidelines followed? A mixed methods study of vancomycin prescribing practices
Jane E. Carland et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2021)
Stability of Vancomycin in Whole Blood
Abinaya Vannapatti Gopalakrishnan et al.
THERAPEUTIC DRUG MONITORING (2021)
Education to improve vancomycin use: the perspectives of educators and education recipients
Bethany A. Van Dort et al.
INTERNAL MEDICINE JOURNAL (2020)
Vancomycin area under the curve to minimum inhibitory concentration ratio predicting clinical outcome: a systematic review and meta-analysis with pooled sensitivity and specificity
B. R. Dalton et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
Vancomycin and creatinine determination in dried blood spots: Analytical validation and clinical assessment
Leticia Scribel et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2020)
Therapeutic monitoring of vancomycin for serious -methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists
Michael J. Rybak et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2020)
The effect of body mass index and creatinine clearance on serum trough concentration of vancomycin in adult patients
Yuyan Pan et al.
BMC INFECTIOUS DISEASES (2020)
How to design a study to evaluate therapeutic drug monitoring in infectious diseases?
A-G Martson et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
Relationship of vancomycin trough levels with acute kidney injury risk: an exposure-toxicity meta-analysis
Ioannis Bellos et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
Assessing the accuracy of two Bayesian forecasting programs in estimating vancomycin drug exposure
Rashmi Shingde et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
Effect of augmented renal clearance on the therapeutic drug monitoring of vancomycin in patients after neurosurgery
Yue Chen et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2020)
A higher dose of vancomycin is needed in critically ill patients with augmented renal clearance
Juan He et al.
TRANSLATIONAL ANDROLOGY AND UROLOGY (2020)
Evidence-based Guideline for Therapeutic Drug Monitoring of Vancomycin: 2020 Update by the Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society
Na He et al.
CLINICAL INFECTIOUS DISEASES (2020)
Where Is the Value of Laboratory Medicine and How Do You Unlock It?
Christopher P. Price et al.
JOURNAL OF APPLIED LABORATORY MEDICINE (2020)
A Multicenter Evaluation of a Nongel Mechanical Separator Plasma Blood Collection Tube for Testing of Selected Therapeutic Drugs
Svetlana Morosyuk et al.
JOURNAL OF APPLIED LABORATORY MEDICINE (2020)
Insufficient harmonization of antibiotics assays - Polish experience with an external quality assessment program in the years 2011-2018
Robert Kowalski et al.
CLINICAL BIOCHEMISTRY (2019)
Vancomycin immunoassay: does the Advia Centaur XPT underestimate the exposure of patients? A method comparison study
Cyril Leven et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2019)
Vancomycin Area Under the Curve and Acute Kidney Injury: A Meta-analysis
Doaa M. Aljefri et al.
CLINICAL INFECTIOUS DISEASES (2019)
Towards precision dosing of vancomycin: a systematic evaluation of pharmacometric models for Bayesian forecasting
A. Broeker et al.
CLINICAL MICROBIOLOGY AND INFECTION (2019)
Indirect derivation of biological variation data and analytical performance specifications for therapeutic drug monitoring activities
Jia Hui Chai et al.
PATHOLOGY (2019)
An evaluation of the user-friendliness of Bayesian forecasting programs in a clinical setting
Zana A. Kumar et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Official International Association for Therapeutic Drug Monitoring and Clinical Toxicology Guideline: Development and Validation of Dried Blood Spot-Based Methods for Therapeutic Drug Monitoring
Sara Capiau et al.
THERAPEUTIC DRUG MONITORING (2019)
Electrochemical Aptamer-Based Sensors for Improved Therapeutic Drug Monitoring and High-Precision, Feedback-Controlled Drug Delivery
Philippe Dauphin-Ducharme et al.
ACS SENSORS (2019)
Vancomycin Pharmacokinetics Throughout Life: Results from a Pooled Population Analysis and Evaluation of Current Dosing Recommendations
Pieter J. Colin et al.
CLINICAL PHARMACOKINETICS (2019)
Construction of a risk prediction model of vancomycin-associated nephrotoxicity to be used at the time of initial therapeutic drug monitoring: A data mining analysis using a decision tree model
Shungo Imai et al.
JOURNAL OF EVALUATION IN CLINICAL PRACTICE (2019)
Twenty-Year Trends in Antimicrobial Susceptibilities Among Staphylococcus aureus From the SENTRY Antimicrobial Surveillance Program (vol 6, pg S47, 2019)
Marcus Zervos
OPEN FORUM INFECTIOUS DISEASES (2019)
Accuracy of intravenous and enteral preparations involving small volumes for paediatric use: a review
L. P. Ainscough et al.
EUROPEAN JOURNAL OF HOSPITAL PHARMACY (2018)
Temporal Stability Evaluation of Drugs in Plasma on Primary Sampling Tube
Virginie Mistretta et al.
THERAPEUTIC DRUG MONITORING (2018)
Implementation of a two-point pharmacokinetic AUC-based vancomycin therapeutic drug monitoring approach in patients with methicillin-resistant Staphylococcus aureus bacteraemia
Bryan T. Mogle et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2018)
Prospective Trial on the Use of Trough Concentration versus Area under the Curve To Determine Therapeutic Vancomycin Dosing
Michael N. Neely et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Design and Implementation of a Novel Web-Based E-Learning Tool for Education of Health Professionals on the Antibiotic Vancomycin
Stuart Evan Bond et al.
JOURNAL OF MEDICAL INTERNET RESEARCH (2017)
The Nephrotoxicity of Vancomycin
E. J. Filippone et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
Establishment of an AUC0-24 Threshold for Nephrotoxicity Is a Step towards Individualized Vancomycin Dosing for Methicillin-Resistant Staphylococcus aureus Bacteremia
R. Chavada et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Pharmacokinetic Characteristics and Clinical Outcomes of Vancomycin in Young Children With Various Degrees of Renal Function
Huanian Zhang et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Evaluation of Vancomycin Exposures Associated with Elevations in Novel Urinary Biomarkers of Acute Kidney Injury in Vancomycin-Treated Rats
Nathaniel J. Rhodes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Impact of an Antimicrobial Stewardship Program on Patient Safety in Veterans Prescribed Vancomycin
Kristen E. Fodero et al.
CLINICAL THERAPEUTICS (2016)
Ultra high performance liquid chromatography-tandem mass spectrometry vs. commercial immunoassay for determination of vancomycin plasma concentration in children. Possible implications for everyday clinical practice
Sebastiano Barco et al.
JOURNAL OF CHEMOTHERAPY (2016)
Augmented Renal Clearance in Patients With Febrile Neutropenia is Associated With Increased Risk for Subtherapeutic Concentrations of Vancomycin
Keita Hirai et al.
THERAPEUTIC DRUG MONITORING (2016)
The impact of a pilot continuing professional development module on hospital pharmacists' preparedness to provide contemporary advice on the clinical use of vancomycin
Cameron J. Phillips et al.
SPRINGERPLUS (2016)
Optimizing the detection of methicillin-resistant Staphylococcus aureus with elevated vancomycin minimum inhibitory concentrations within the susceptible range
Cameron J. Phillips et al.
INFECTION AND DRUG RESISTANCE (2016)
MRSA from Santa Catarina State, Southern Brazil: intriguing epidemiological differences compared to other Brazilian regions
Alessandro C. O. Silveira et al.
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES (2015)
Novel LC-MS/MS method for plasma vancomycin: Comparison with immunoassays and clinical impact
Matthijs Oyaert et al.
CLINICA CHIMICA ACTA (2015)
Vancomycin Trough Concentration as a Predictor of Clinical Outcomes in Patients with Staphylococcus aureus Bacteremia: A Meta-analysis of Observational Studies
John P. Prybylski
PHARMACOTHERAPY (2015)
Innovative approaches to optimizing the delivery of vancomycin in individual patients
Manjunath P. Pai et al.
ADVANCED DRUG DELIVERY REVIEWS (2014)
Method-specific performance of vancomycin MIC susceptibility tests in predicting mortality of patients with methicillin-resistant Staphylococcus aureus bacteraemia
Shey-Ying Chen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Precision of Vancomycin and Daptomycin MICs for Methicillin-Resistant Staphylococcus aureus and Effect of Subculture and Storage
Carmen L. Charlton et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
Comparability and Imprecision of 8 Frequently Used Commercially Available Immunoassays for Therapeutic Drug Monitoring
Maria Shipkova et al.
THERAPEUTIC DRUG MONITORING (2014)
Systematic Review and Meta-Analysis of Vancomycin-Induced Nephrotoxicity Associated with Dosing Schedules That Maintain Troughs between 15 and 20 Milligrams per Liter
S. J. van Hal et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Quantification of vancomycin in human serum by LC-MS/MS
Katrin Koenig et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2013)
Is It Time to Replace Vancomycin in the Treatment of Methicillin-Resistant Staphylococcus aureus Infections?
Sebastiaan J. van Hal et al.
CLINICAL INFECTIOUS DISEASES (2013)
Vancomycin pharmacodynamics and survival in patients with methicillin-resistant Staphylococcus aureus-associated septic shock
Sheryl Zelenitsky et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
Evaluation of Vancomycin Susceptibility Testing for Methicillin-Resistant Staphylococcus aureus: Comparison of Etest and Three Automated Testing Methods
Michael J. Rybak et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
Adherence to the 2009 Consensus Guidelines for Vancomycin Dosing and Monitoring Practices: A Cross-Sectional Survey of US Hospitals
Susan L. Davis et al.
PHARMACOTHERAPY (2013)
What Proportion of Vancomycin Trough Levels Are Drawn Too Early? Frequency and Impact on Clinical Actions
Aileen P. Morrison et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2012)
Influence of separator gel in Sarstedt S-Monovette® serum tubes on various therapeutic drugs, hormones, and proteins
Sofie Schouwers et al.
CLINICA CHIMICA ACTA (2012)
The Clinical Significance of Vancomycin Minimum Inhibitory Concentration in Staphylococcus aureus Infections: A Systematic Review and Meta-analysis
S. J. van Hal et al.
CLINICAL INFECTIOUS DISEASES (2012)
Improving vancomycin prescription in critical illness through a drug use evaluation process: a weight-based dosing intervention study
Janice Li et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Augmented renal clearance in septic patients and implications for vancomycin optimisation
Joao Pedro Baptista et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Is Vancomycin MIC Creep Method Dependent? Analysis of Methicillin-Resistant Staphylococcus aureus Susceptibility Trends in Blood Isolates from North East Scotland from 2006 to 2010
B. Edwards et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
Prediction of Failure in Vancomycin-Treated Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: a Clinically Useful Risk Stratification Tool
Carol L. Moore et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Minimization of the Preanalytical Error in Plasma Samples for Pharmacokinetic Analyses and Therapeutic Drug Monitoring - Using Doxorubicin as an Example
Nina E. Kontny et al.
THERAPEUTIC DRUG MONITORING (2011)
Vancomycin pharmacokinetics in patients with severe burn injuries
Michael Dolton et al.
BURNS (2010)
Vancomycin Pharmacokinetics and Pharmacodynamics during Short Daily Hemodialysis
Brian S. Decker et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Accuracy of Commercial and Reference Susceptibility Testing Methods for Detecting Vancomycin-Intermediate Staphylococcus aureus
Jana M. Swenson et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Population pharmacokinetic analysis of vancomycin in patients with gram-positive infections and the influence of infectious disease type
M. Yamamoto et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2009)
Therapeutic Monitoring of Vancomycin in Adults Summary of Consensus Recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists
Michael J. Rybak et al.
PHARMACOTHERAPY (2009)
Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists
M. Rybak et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2008)
Vancomycin MICs for Methicillin-Resistant Staphylococcus aureus Isolates Differ Based upon the Susceptibility Test Method Used
V. Prakash et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin
T. P. Lodise et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Comparison of method-specific vancomycin minimum inhibitory concentration values and their predictability for treatment outcome of meticillin-resistant Staphylococcus aureus (MRSA) infections
Donald I. Hsu et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2008)
Vancomycin pharmacokinetics in critically ill patients receiving continuous venovenous haemodiafiltration
ME DelDot et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2004)
The World Health Organization's External Quality Assurance System proficiency testing program has improved the accuracy of antimicrobial susceptibility testing and reporting among participating laboratories using NCCLS methods
JM Chaitram et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Stability of therapeutic drugs in serum collected in vacutainer serum separator tubes containing a new gel (SST II)
V Bush et al.
THERAPEUTIC DRUG MONITORING (2001)
Time-dependent absorption of therapeutic drugs by the gel of the Greiner Vacuette blood collection tube
A Dasgupta et al.
THERAPEUTIC DRUG MONITORING (2000)
分享论文
